$SCND 3 SEC Filings

Filed On	Filing
29 Dec 2025	Form 3: Rovinsky Zachary, Chief Financial Officer
31 Jul 2024	Form 3: Nicols John J, Director
26 Apr 2024	Form 3: Blechman Michael, Director No securities owned
14 Feb 2024	Form 3: North Run CAPITAL, Lp, 10% owner and 3 others Holds 575,000 shares of Common Stock
13 Jul 2022	Form 3: Averilla Reginald, Chief Financial Officer
24 Jun 2021	Form 3: Bleichroeder Lp, 10% owner Holds 557,895 shares of Common Stock
07 May 2021	Form 3: Veradace Partners Lp, 10% owner Holds 637,928 shares of Common Stock
09 Apr 2021	Form 3: Polk James B, Chief Commercial Officer
24 Jul 2020	Form 3: Cremonese Joseph G, Director
09 Jul 2020	Form 3: Polk Lyon, 10% owner Holds 222,000 shares of Common Stock
26 Jun 2020	Form 3: Cox Christopher T, 10% owner Holds 222,000 shares of Common Stock
24 Jun 2020	Form 3: Eddleman Roy T, 10% owner Holds 811,835 shares of Common stock, $.05 par value
24 May 2019	Form 3: Frampton Marcus, Director Holds 81,812 shares of COMMON STOCK
09 Apr 2019	Form 3: Watkins John F F, Director No securities owned
09 Apr 2019	Form 3: Moore John A, Director
04 Oct 2017	Form 3: March Brookman Peter, Vice President
26 Sep 2014	Form 3: Nowosielski Karl, President-Division
27 Aug 2012	Form 3: March Brookman Peter, President, Subsidiary Holds 89,450 shares of Common Stock
27 Jun 2011	Form 3: Spectrum Laboratories Inc /CA, 10% owner Holds 127,986 shares of Common Stock
14 Sep 2007	Form 3: Morin Grace Sanborn, Director Holds 112,950 shares of Common Stock

Comments